The epilepsy bioinformatics study for anti-epileptogenic therapy (EpiBioS4Rx) clinical biomarker

Study design and protocol

For the EpiBioS4Rx Study Group

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The Epilepsy Bioinformatics Study for Anti-epileptogenic Therapy (EpiBioS4Rx) is a longitudinal prospective observational study funded by the National Institute of Health (NIH) to discover and validate observational biomarkers of epileptogenesis after traumatic brain injury (TBI). A multidisciplinary approach has been incorporated to investigate acute electrical, neuroanatomical, and blood biomarkers after TBI that may predict the development of post-traumatic epilepsy (PTE). We plan to enroll 300 moderate-severe TBI patients with a frontal and/or temporal lobe hemorrhagic contusion. Acute evaluation with blood, imaging and electroencephalographic monitoring will be performed and then patients will be tracked for 2 years to determine the incidence of PTE. Validation of selected biomarkers that are discovered in planned animal models will be a principal feature of this work. Specific hypotheses regarding the discovery of biomarkers have been set forth in this study. An international cohort of 13 centers spanning 2 continents will be developed to facilitate this study, and for future interventional studies.

Original languageEnglish (US)
JournalNeurobiology of Disease
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Computational Biology
Epilepsy
Post-Traumatic Epilepsy
Biomarkers
Contusions
National Institutes of Health (U.S.)
Frontal Lobe
Temporal Lobe
Therapeutics
Observational Studies
Animal Models
Prospective Studies
Clinical Studies
Incidence
Traumatic Brain Injury

ASJC Scopus subject areas

  • Neurology

Cite this

The epilepsy bioinformatics study for anti-epileptogenic therapy (EpiBioS4Rx) clinical biomarker : Study design and protocol. / For the EpiBioS4Rx Study Group.

In: Neurobiology of Disease, 01.01.2018.

Research output: Contribution to journalArticle

@article{4c70195c989f417fa11727fbe2c2162d,
title = "The epilepsy bioinformatics study for anti-epileptogenic therapy (EpiBioS4Rx) clinical biomarker: Study design and protocol",
abstract = "The Epilepsy Bioinformatics Study for Anti-epileptogenic Therapy (EpiBioS4Rx) is a longitudinal prospective observational study funded by the National Institute of Health (NIH) to discover and validate observational biomarkers of epileptogenesis after traumatic brain injury (TBI). A multidisciplinary approach has been incorporated to investigate acute electrical, neuroanatomical, and blood biomarkers after TBI that may predict the development of post-traumatic epilepsy (PTE). We plan to enroll 300 moderate-severe TBI patients with a frontal and/or temporal lobe hemorrhagic contusion. Acute evaluation with blood, imaging and electroencephalographic monitoring will be performed and then patients will be tracked for 2 years to determine the incidence of PTE. Validation of selected biomarkers that are discovered in planned animal models will be a principal feature of this work. Specific hypotheses regarding the discovery of biomarkers have been set forth in this study. An international cohort of 13 centers spanning 2 continents will be developed to facilitate this study, and for future interventional studies.",
author = "{For the EpiBioS4Rx Study Group} and Vespa, {Paul M.} and Vikesh Shrestha and Nicholas Abend and Denes Agoston and Alicia Au and Bell, {Michael J.} and Bleck, {Thomas P.} and Blanco, {Manuel Buitrago} and Ben Ellingson and Gilmore, {Emily J.} and Lawrence Hirsch and Martin Hunn and Alaa Kamnaksh and David McArthur and Andrew Morokoff and Terrence O'Brien and Kristine O'Phelan and Robertson, {Courtney L.} and Eric Rosenthal and Richard Staba and Willyerd, {Frederick A.} and Elisa Yam and Susana Martinez and Courtney Real and Jerome Engel and Denes Agoston and Alicia Au and Bell, {Michael J.} and {Bleck Thomas}, P. and Craig Branch and {Buitrago Blanco}, Manuel and Ross Bullock and Branch, {Craig A.} and Jan Claassen and Robert Clarke and James Cloyd and Lisa Coles and Karen Crawford and Ramon Diaz-Arrastia and Dominique Duncan and Benjamin Ellingson and Galanopoulou, {Aristea S.} and Brandon Foreman and Aristea Galanopoulou and Emily Gilmore and Olli Grohn and Neil Harris and Jed Hartings and Moshe, {Solomon L.} and Mowrey, {Wenzhu Bi}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.nbd.2018.07.025",
language = "English (US)",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - The epilepsy bioinformatics study for anti-epileptogenic therapy (EpiBioS4Rx) clinical biomarker

T2 - Study design and protocol

AU - For the EpiBioS4Rx Study Group

AU - Vespa, Paul M.

AU - Shrestha, Vikesh

AU - Abend, Nicholas

AU - Agoston, Denes

AU - Au, Alicia

AU - Bell, Michael J.

AU - Bleck, Thomas P.

AU - Blanco, Manuel Buitrago

AU - Ellingson, Ben

AU - Gilmore, Emily J.

AU - Hirsch, Lawrence

AU - Hunn, Martin

AU - Kamnaksh, Alaa

AU - McArthur, David

AU - Morokoff, Andrew

AU - O'Brien, Terrence

AU - O'Phelan, Kristine

AU - Robertson, Courtney L.

AU - Rosenthal, Eric

AU - Staba, Richard

AU - Willyerd, Frederick A.

AU - Yam, Elisa

AU - Martinez, Susana

AU - Real, Courtney

AU - Engel, Jerome

AU - Agoston, Denes

AU - Au, Alicia

AU - Bell, Michael J.

AU - Bleck Thomas, P.

AU - Branch, Craig

AU - Buitrago Blanco, Manuel

AU - Bullock, Ross

AU - Branch, Craig A.

AU - Claassen, Jan

AU - Clarke, Robert

AU - Cloyd, James

AU - Coles, Lisa

AU - Crawford, Karen

AU - Diaz-Arrastia, Ramon

AU - Duncan, Dominique

AU - Ellingson, Benjamin

AU - Galanopoulou, Aristea S.

AU - Foreman, Brandon

AU - Galanopoulou, Aristea

AU - Gilmore, Emily

AU - Grohn, Olli

AU - Harris, Neil

AU - Hartings, Jed

AU - Moshe, Solomon L.

AU - Mowrey, Wenzhu Bi

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The Epilepsy Bioinformatics Study for Anti-epileptogenic Therapy (EpiBioS4Rx) is a longitudinal prospective observational study funded by the National Institute of Health (NIH) to discover and validate observational biomarkers of epileptogenesis after traumatic brain injury (TBI). A multidisciplinary approach has been incorporated to investigate acute electrical, neuroanatomical, and blood biomarkers after TBI that may predict the development of post-traumatic epilepsy (PTE). We plan to enroll 300 moderate-severe TBI patients with a frontal and/or temporal lobe hemorrhagic contusion. Acute evaluation with blood, imaging and electroencephalographic monitoring will be performed and then patients will be tracked for 2 years to determine the incidence of PTE. Validation of selected biomarkers that are discovered in planned animal models will be a principal feature of this work. Specific hypotheses regarding the discovery of biomarkers have been set forth in this study. An international cohort of 13 centers spanning 2 continents will be developed to facilitate this study, and for future interventional studies.

AB - The Epilepsy Bioinformatics Study for Anti-epileptogenic Therapy (EpiBioS4Rx) is a longitudinal prospective observational study funded by the National Institute of Health (NIH) to discover and validate observational biomarkers of epileptogenesis after traumatic brain injury (TBI). A multidisciplinary approach has been incorporated to investigate acute electrical, neuroanatomical, and blood biomarkers after TBI that may predict the development of post-traumatic epilepsy (PTE). We plan to enroll 300 moderate-severe TBI patients with a frontal and/or temporal lobe hemorrhagic contusion. Acute evaluation with blood, imaging and electroencephalographic monitoring will be performed and then patients will be tracked for 2 years to determine the incidence of PTE. Validation of selected biomarkers that are discovered in planned animal models will be a principal feature of this work. Specific hypotheses regarding the discovery of biomarkers have been set forth in this study. An international cohort of 13 centers spanning 2 continents will be developed to facilitate this study, and for future interventional studies.

UR - http://www.scopus.com/inward/record.url?scp=85050387436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050387436&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2018.07.025

DO - 10.1016/j.nbd.2018.07.025

M3 - Article

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -